Webster Equity Partners

Webster Equity Partners focuses on control buyouts and growth recapitalizations in North American healthcare services and consumer businesses. The firm targets founder-led companies with $5 million to $25 million in EBITDA, building regional platforms through consolidation. Its healthcare work has concentrated on physician practice management, including veterinary care, dermatology, dental services, and behavioral health.

Webster does not publicly list exclusionary sectors, but its investment record indicates no meaningful activity in hard technology, energy, financial services, or real estate. The firm's narrow healthcare-and-consumer mandate effectively screens out industries where it lacks operational expertise.

Webster does not publicly disclose AUM. Public filings indicate Fund IV closed at $590 million in 2019, and the firm began raising Fund V targeting over $700 million in 2021 (per SEC filings). These figures place Webster among the larger lower-middle-market buyout firms, with a fund size sufficient to write equity checks up to approximately $100 million.

Webster Equity Partners invests directly, taking control or significant minority positions. There is no public evidence the firm operates as a fund-of-funds or allocates capital to external managers. Its model relies on in-house sourcing, due diligence, and portfolio operations teams.

Webster Equity Partners was founded by a group of investment professionals whose current leadership roster is not comprehensively published on the firm's website. The investment committee makes decisions collectively, a structure common among lower-middle-market private equity firms. Individual partner names and biographical details are sparse in the public record.